Lantern Pharma Inc.
Ticker: LTRN
| Insider | Title |
|---|---|
| Aaron G.l. Fletcher | 10% or greater ownership |
| Advisors Gp, Llc Bios | 10% or greater ownership |
| Advisors, Llc Cavu | 10% or greater ownership |
| Capital Management, Lp Bios | 10% or greater ownership |
| D Jeffrey Keyser | Director |
| David R. Margrave | Chief Financial Officer |
| David S. Silberstein | Director |
| Directors, Lp Bp | 10% or greater ownership |
| Equity Partners Ii, Lp Bios | 10% or greater ownership |
| Equity Partners, Lp Bios | 10% or greater ownership |
| Franklyn G Prendergast | Director |
| Fund I Qp, Lp Bios | 10% or greater ownership |
| Fund I, Lp Bios | 10% or greater ownership |
| Fund Ii Nt, Lp Bios | 10% or greater ownership |
| Fund Ii Qp, Lp Bios | 10% or greater ownership |
| Fund Ii, Lp Bios | 10% or greater ownership |
| Kishor G. Bhatia | Chief Scientific Officer |
| Leslie W. Kreis | 10% or greater ownership |
| Management, Lp Cavu | 10% or greater ownership |
| Maria-luisa Maccecchini | Director |
| Panna Sharma | President and CEO, Director |
| Vijay Chandru | Director |